#NSE Vikas Lifecare Ltd.
Explore tagged Tumblr posts
Text
Vikas Lifecare Ltd.: A Closer Look at the Company's Performance and Share Price
Introduction: Vikas Lifecare Ltd. is a pharmaceutical company based in India that specializes in the production and distribution of active pharmaceutical ingredients (APIs) and finished dosage formulations (FDFs). The company has gained attention for its focus on developing cost-effective solutions for various health conditions. Investors who are interested in understanding the company's performance and share price could refer to Ticker by Finology's share price tracker.
A Brief Overview of Vikas Lifecare Ltd.: Vikas Lifecare Ltd. operates through two segments: the pharmaceutical segment and the non-pharmaceutical segment. The pharmaceutical segment is focused on manufacturing, trading, and exporting APIs and FDFs, while the non-pharmaceutical segment engages in trading and exporting other genres of products.
Vikas Lifecare Ltd.’s Share Price Tracker on Ticker by Finology: Ticker by Finology offers investors a share price tracker for Vikas Lifecare Ltd.. This tracker provides information such as the current market price, complete price chart for the past six months, and other relevant financial metrics such as the market cap, balance sheet, and quarterly results.
Analyzing the Company’s Performance: The share price tracker by Ticker by Finology allows investors to track Vikas Lifecare Ltd.’s performance on a real-time basis. Investors can use this information to assess the company’s growth potential, its ability to withstand market risks, and its market position.
Market Dynamics and Development: Currently, Vikas Lifecare Ltd. operates in a highly competitive market where product innovation, cost-effectiveness, and quality assurance are essential to retain and expand the customer base. The company has a diverse product portfolio, and the focus on research and development is likely to be a driving force behind the company’s growth and sustainability.
Investment Strategy: Investors interested in Vikas Lifecare Ltd. can refer to Ticker by Finology’s share price tracker as well as perform additional research to make informed investment decisions. It’s important to identify the company’s growth potential, financial performance, and competitive landscape to make well-informed investment decisions. Investors should also keep an eye on market trends and changes in the regulatory landscape while regularly reassessing their investment portfolio.
Conclusion: Vikas Lifecare Ltd. is a pharmaceutical company that has gained recognition for its focus on developing cost-effective solutions for various health conditions. Investors who are interested in exploring the company's potential can refer to Ticker by Finology's share price tracker to gain valuable insights. However, it is crucial to conduct thorough research and analysis before making investment decisions to maximize potential returns while minimizing risks.
0 notes
Text
Vikas Lifecare Limited Announces Strategic Collaboration for Nano Composites Development
On August 5, 2024, Vikas Lifecare Limited made a significant announcement regarding a strategic collaboration with leading research institutions. The company has partnered with the Defence Electronic Applications Laboratory (DEAL), a premier laboratory under the Defence Research and Development Organisation (DRDO) in Dehradun, the Indian Institute of Technology (IIT) Delhi, and the CSIR-National Physical Laboratory (CSIR-NPL) in Delhi. This partnership aims to advance the development of Nano composites for Electromagnetic Interference (EMI) shielding applications, targeting a wide range of commercial, military, and scientific electronic devices, as well as communication instruments.
The collaboration was formalized through a Non-Disclosure Agreement (NDA) signed by all parties involved, underscoring the commitment to confidentiality and shared innovation. The primary objective of this partnership is to design and develop advanced carbon fiber and multi-walled carbon nanotubes (MWCNT)/graphene nano ferrites composites specifically for EMI shielding applications. These efforts will focus on creating nano composites using exfoliated graphite blended with MWCNT in a polymer matrix or carbon fibers polymer composites, and incorporating silver and copper nanoparticles to enhance electrical and thermal conductivity.
The project will also involve optimizing processing and material parameters to ensure the production of high-performance nano composite products. These advanced materials are expected to provide superior performance characteristics, meeting the stringent requirements of various high-stakes applications, including those in the defense sector.
Dr. Sundeep Kumar Dhawan, Managing Director of Vikas Lifecare Limited, expressed his enthusiasm about the collaboration, stating, "We are thrilled to partner with prestigious institutions like DEAL, DRDO, IIT Delhi, and CSIR-NPL. This collaboration aligns with our commitment to innovation and excellence. We look forward to developing cutting-edge Nano composites that will significantly enhance the performance and reliability of electronic devices across various sectors."
Dr. I. M. Chhabra, Group Director (CAME) of DEAL, DRDO, highlighted the strategic importance of the collaboration, saying, "The development of advanced EMI shielding materials is of paramount importance for the defense sector. Our collaboration with Vikas Lifecare Limited, IIT Delhi, and CSIR-NPL will leverage our combined expertise to create state-of-the-art solutions that meet the evolving needs of the industry."
This partnership represents a significant step forward in the field of EMI shielding, which is critical for protecting electronic devices from electromagnetic interference. By combining the expertise and resources of all participating institutions, the project aims to deliver breakthrough innovations that will set new benchmarks in the industry.
Vikas Lifecare Limited, an NSE and BSE listed company, is an ISO 9001:2015 certified entity engaged in the manufacturing and trading of Polymer and Rubber compounds and Specialty Additives for Plastics, Synthetic & Natural Rubber. The company has a strong focus on sustainability, manufacturing upcycled compounds from industrial and post-consumer waste materials, thereby contributing to environmental protection initiatives and fulfilling mandated Extended Producer Responsibility (EPR) obligations.
Additionally, Vikas Lifecare Limited's subsidiary, Genesis Gas Solutions Pvt. Ltd., is a key player in the smart gas metering market in India, with a substantial share in the domestic gas metering market. The subsidiary has entered a joint venture with Indraprastha Gas Limited (IGL) to establish a manufacturing plant for gas meters based on advanced technology, further solidifying the company's position in the industry.
In a strategic move to diversify its business interests, Vikas Lifecare Limited has ventured into the B2C segment with a range of consumer products, including FMCG, Agro, and Infrastructure products. The company is also making strides in the entertainment sector with a new venture in film production. Its debut project, "Lioness," in collaboration with Teamo Productions HQ Limited, highlights Vikas Lifecare Limited's commitment to quality storytelling and cultural representation.
As the company continues to explore new horizons and create memorable experiences for audiences worldwide, it remains dedicated to innovation and excellence in all its endeavors. This latest collaboration with DEAL-DRDO, IIT Delhi, and CSIR-NPL is yet another testament to Vikas Lifecare Limited's vision for the future.
0 notes
Text
Vikas Lifecare Limited Meeting on June 1st, 2024
In the bustling boardrooms of Vikas Lifecare Limited, decisions were made that would reverberate across the stock exchanges. On June 1, 2024, the company, a prominent figure in the NSE/BSE listings under the symbol VIKASLIFE, held a pivotal Board Meeting. This meeting marked a significant juncture as the Board of Directors convened to address critical matters, including the conversion of 2,30,00,000 warrants into an equivalent number of equity shares.
Following a series of communications dating back to March 2024, wherein initial allotments of warrants were issued and subsequent conversion procedures outlined, Vikas Lifecare Limited disclosed the outcomes of their deliberations in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board's decision to convert warrants into equity shares at an issue price of Rs. 4/- each (including a premium of Rs. 3/- each) signifies a strategic move aimed at bolstering the company's capital structure.
The conversion, executed on preferential terms, entailed the allotment of equity shares to both Promoters and the Non-Promoter/Public Category, contingent upon the receipt of the remaining balance amount totaling Rs. 6,90,00,000/-. This step not only enhances Vikas Lifecare's financial framework but also aligns with their strategic growth objectives.
Underpinning these developments is the adherence to regulatory frameworks set forth by SEBI (ICDR) Regulations, 2018, ensuring transparency and compliance throughout the process. The detailed allotment breakdown reflects a meticulous approach, with entities like M/s. Sylph Technologies Ltd, M/s. Dues Manager Private Limited, and individual investor Prajal Bhandari participating actively in the equity expansion.
With the conclusion of this Board Meeting, Vikas Lifecare Limited's issued and paid-up capital now stands enhanced at Rs. 181,03,68,560/-, represented by 181,03,68,560 equity shares of Re. 1/- each. Importantly, the newly allotted equity shares maintain parity with existing shares, reinforcing equity among stakeholders.
As the company navigates these transformative steps, it remains committed to robust governance and shareholder value enhancement. This proactive stance underscores Vikas Lifecare Limited's resilience and forward-looking approach in the dynamic realm of capital markets.
0 notes
Text
Advik Capital Ltd. Acquires Stake in Industrial Investment Trust Limited: A Strategic Move in the Financial Sector
Advik Capital Limited, a leading player in the financial landscape, has made a significant stride in its growth journey by acquiring a substantial stake in M/s Industrial Investment Trust Limited (IITL). In an all-cash deal amounting to approximately Rs. 2586.95 million, Advik Capital, along with its promoter Dr. Vikas Garg and Vikas Lifecare Limited, has taken a step towards consolidating its position in the market.
The acquisition, aimed at gaining control and management of IITL, involves purchasing 41.72% of the total outstanding share capital of the target company. This strategic move underscores Advik Capital's commitment to expanding its market presence and enhancing its offerings.
In a statement, Mr. Vikas Garg, promoter of Advik Capital, expressed enthusiasm about the acquisition, highlighting its significance in the company's strategic growth trajectory. He emphasized the potential for strengthening market positioning, exploring new markets, and enhancing product offerings.
Established in 1933, IITL has been a prominent player in India's financial market landscape, offering a range of financial products and services including loan against property, lease rental discounting, loan against securities, private equity, and margin funding. With its listing on the Bombay Stock Exchange Limited (BSE) and the National Stock Exchange of India Limited (NSE), IITL has maintained a strong track record of profitability and shareholder value creation.
The rationale behind Advik Capital's investment in IITL is aligned with its vision to diversify offerings and enhance capabilities to cater to evolving customer needs. By leveraging synergies between the two entities, Advik Capital aims to drive growth and innovation in the financial sector.
The Indian Non-Banking Financial Company (NBFC) sector has witnessed remarkable growth in recent years, playing a pivotal role in bridging the credit gap and driving financial inclusion. Advik Capital's strategic move exemplifies its commitment to contributing to this growth trajectory and solidifying its position as a key player in the financial ecosystem.
Dr. Vikas Garg, with over 25 years of experience in managing financial businesses, brings invaluable expertise to Advik Capital's strategic initiatives. His leadership, coupled with Advik Capital's market insight and financial acumen, positions the company for sustained growth and value creation.
In addition to its core business of providing financial loans, Advik Capital's subsidiary, Advikca Finvest Limited, is engaged in making investments in capital markets instruments, both in India and abroad.
As Advik Capital continues to explore opportunities for growth and expansion, it remains committed to creating value for its stakeholders while adhering to the highest standards of corporate governance and regulatory compliance.
0 notes
Text
Vikas Lifecare Limited Expands Its Horizon: Acquires Substantial Stake in Industrial Investment Trust Limited
In a significant move, Vikas Lifecare Limited (VLL), a notable entity listed on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE), has announced its acquisition of a substantial stake in M/s Industrial Investment Trust Limited (IITL). This strategic investment, undertaken in collaboration with Dr. Vikas Garg and Advik Capital Limited, marks a milestone in VLL's journey towards diversification and growth in the financial sector.
Key Highlights of the Acquisition: VLL, together with its promoter Dr. Vikas Garg and Advik Capital Limited, has acquired a significant equity stake in IITL, a renowned Non-Banking Finance Company (NBFC), in an all-cash deal amounting to approximately Rs. 2586.95 million.
The transaction involves the purchase of 41.72% of IITL's total outstanding share capital, consolidating VLL's position in the financial market.
Dr. Vikas Garg, commenting on the acquisition, expressed optimism about the synergies between the two entities and emphasized the strategic significance of this move in enhancing VLL's market presence and product offerings.
About Industrial Investment Trust Limited (IITL): Established in 1933, IITL has been a prominent player in India's financial market landscape, providing expert advice on investment portfolios. Over the years, it has diversified its offerings to include a range of financial products and services, such as loan against property, lease rental discounting, loan against securities, private equity, margin funding, and investments in shares, stocks, debentures, and bonds.
The rationale behind the Investment/Acquisition: The acquisition aligns with VLL's vision to diversify its offerings and strengthen its capabilities to cater to evolving customer needs. By joining forces with Advik Capital Limited, VLL aims to leverage synergies, tap into each other's expertise, and drive growth and innovation in the financial sector.
About Non-Banking Financial Companies (NBFCs): NBFCs have emerged as significant players in India's financial landscape, bridging the gap between traditional banking and catering to the financial needs of various segments of society. With their flexible approach, focus on innovation, and ability to bridge credit gaps, NBFCs have revolutionized the financial ecosystem in India.
About Advik Capital Limited: Headquartered in New Delhi, Advik Capital Limited is a non-deposit-taking NBFC registered with the Reserve Bank of India. The company primarily engages in providing financial loans and ancillary services, with its equity shares frequently traded on the Bombay Stock Exchange Ltd.
About Dr. Vikas Garg: Dr. Vikas Garg, a seasoned finance professional with over 25 years of experience, holds a Doctorate in Business Administration from the University of Queen Mary, United Kingdom. His expertise spans various domains of finance, lending, and investments, making him a respected figure in the finance industry.
About Vikas Lifecare Limited: Vikas Lifecare Limited is an ISO 9001:2015 certified company engaged in the manufacturing and trading of polymer and rubber compounds, specialty additives for plastics, synthetic and natural rubber, and smart gas meters. With a focus on diversification and expansion, VLL has ventured into various business segments, including FMCG, agro, infrastructure products, and entertainment.
0 notes
Text
Genesis Gas Solutions Announces Joint Venture and Paid-Up Capital Inducement
Vikas Lifecare Limited's subsidiary, Genesis Gas Solutions Pvt. Ltd., has successfully incorporated "IGL Genesis Technologies Limited," a joint venture with Indraprastha Gas Limited (IGL). This strategic move has been marked by the induction of a paid-up capital totaling INR 181 Million.
Joint Venture Highlights:
The newly formed "IGL Genesis Technologies Limited" is a collaboration between IGL and Genesis Gas Solutions, with equity participation at a ratio of 51:49, respectively.
The venture aims to establish India's first Integrated Smart Meter Manufacturing Plant, aligning with the Make in India initiative.
The manufacturing facility, located in NOIDA, Uttar Pradesh, is set to be operational by July 2024, initially producing 1 million smart meters annually.
Technological Advancements:
The smart meters manufactured by "IGL Genesis Technologies Limited" will incorporate cutting-edge IoT technologies such as LoRa, LoRaWAN, Bluetooth, NFC, and NB-IoT.
The company will develop software with built-in Smart Analytics, Dashboards, Predictive Maintenance Protocols, and Allied Systems.
Global Reach and Market Potential:
The joint venture aims to meet the high demand for smart meters, catering to domestic consumers and targeting the international market.
The technology-based metering solutions focus on long-range communications, low power networks, automated metering, and pre-paid metering.
Genesis Gas Solutions Pvt Ltd's Achievements:
Genesis is a pioneer in Smart Gas and Water Metering in India, holding a substantial market share.
The company has supplied gas meters to industry leaders, including Gujarat Gas Limited and Avantika Gas Limited.
Genesis has introduced Ultrasonic Meters, 4G Modems, and Bluetooth-based Smart Meters, showcasing its commitment to innovation.
The company has diversified into commercial pipeline laying contracts for Indian Oil Adani Gas Pvt Ltd.
About Vikas Lifecare Limited: Vikas Lifecare Limited is an ISO 9001:2015 certified company engaged in manufacturing and trading Polymer and Rubber compounds.
The company, listed on both BSE (Scrip Code: 542655) and NSE (Symbol: VIKASLIFE), is a key player in contributing to environmental protection initiatives.
0 notes
Text
Genesis Gas Solutions Pvt Ltd, a subsidiary of Vikas Lifecare, has received its first-ever orders for Ultrasonic Gas Meters valued at INR 30 Million.
Vikas Lifecare Limited has announced that its subsidiary, Genesis Gas Solutions Pvt. Ltd (Genesis), has received orders for Ultrasonic Gas Meters valued at INR 30 Million. These meters are highly accurate and reliable as they measure the gas volume flow by analyzing the transit times of high-frequency sound waves. They are particularly useful for Large Diameter Gas Pipe Lines, where mechanical drive meters can result in commercial losses.
The Ultrasonic meters supplied by Genesis will be used by various City Gas Distribution companies as part of their Field Regulating Skid (FRS). Genesis had previously signed an agreement with SICK AG, Germany to provide Ultrasonic Gas Meters (FlowSic 500) for Industrial and Commercial gas customers. Genesis has also integrated its own MDM solution, EnerDash, with the Ultrasonic meters (FlowSic 500) to enhance their functionality.
About Genesis Gas Solutions Pvt Ltd: Genesis Gas Solutions Pvt Ltd was established in 2017 by a team of technopreneurs and finance professionals with a focus on the City Gas Distribution sector in India. The company is a pioneer in Smart Gas and Water Metering and currently holds about 20% of the Domestic Gas Metering market share in India.
Genesis has achieved several notable accomplishments in the industry, including:
Supplying Gas meters to various CGDs of India and providing after-sales services under an exclusive supply arrangement, having supplied over 4 lakh meters of Hangzhou Beta Meter Co. Ltd.
Providing Smart Meter Interface Unit (MIU) and associated services to Indraprastha Gas Ltd, a JV of GAIL, BPCL, and the Government of NCT of Delhi.
Offering smart metering solutions (AMR & Prepaid) with RF-based Lora WAN technology in partnership with Tata Communications.
Developing India’s first Meter Data Management (MDM) and Head end system for Gas utilities, which operates over 150,000 smart meters in India.
Creating its own network solution to complement its field devices, which is being recognized by global companies such as Honeywell and Hitachi, who are testing these products for their projects worldwide.
About Vikas Lifecare Ltd: Vikas Lifecare Ltd. (VLL) is a certified ISO 9001:2015 company that trades and manufactures polymer, rubber compounds, and additives for plastics, synthetic, and natural rubber. The company operates in various business segments, including Polymer & Rubber Commodity Compounds and MasterBatches. VLL contributes to the Environment Protection initiatives of the Government of India by manufacturing up-cycled compounds from industrial and post-consumer waste materials like EVA, PVC, PP, PE, etc., and fulfilling the mandated EPR obligations for conglomerates consuming large amounts of plastic products and packaging materials.
VLL is a Del-Credere agent of ONGC Petro Additions Limited, a public sector undertaking producing a wide range of base polymers and commodity plastic raw materials.
Recently, VLL has diversified its business interests beyond raw materials and entered the B2C segment with a range of consumer products, including FMCG, Agro, and Infrastructure Products. The company plans to expand its business growth through intricately planned and selected product portfolios via acquisitions, joint ventures, and tie-ups.
VLL’s subsidiary, Genesis Gas Solutions Pvt. Ltd., is a major supplier of Smart Gas Meters to all major Gas Distribution Companies in India for domestic and commercial consumers. Genesis is a pioneer in Smart Gas and Water Metering and currently holds about 20% of the Domestic Gas Metering business share in India.
The company’s securities are listed on both the Stock Exchanges, BSE (Scrip Code: 542655) and NSE (Symbol: VIKASLIFE).
1 note
·
View note
Text
Vikas Lifecare's material subsidiary Genesis Gas Solutions was awarded the Technical Advisory Contract by Dornier Group GmbH for their ongoing project in Mali, Africa
Vikas Lifecare Limited is pleased to inform you that its material subsidiary Genesis Gas Solutions Private Limited has been awarded the contract to give specialized advisory for the Optimization of Battery Storage Systems for Distribution Grid Applications by the Dornier Group GmbH at their ongoing design in Mali, Africa.
Dornier Group lately hosted a mate meeting in New Delhi with their South Asian indigenous mates from India, Bangladesh, and Nepal where Dornier and the transnational mates participated in moxie and bandied cooperation systems and recent request developments. colorful strategies for unborn collaborations were also bandied.
Genesis will also give the Test Specialist and will also work their O&M experience for Renewable Power systems in Mali, Africa. Genesis is poised to develop service models for India’s forthcoming Power Distribution Grid Applications to support Renewable Power systems including Battery, Solar, and Wind Power for sustainable pastoral municipalities in India. Genesis will also work in close cooperation with Dornier Group for other Renewable Energy, and Clean Energy systems that Dornier is developing in India and the South Asian Region.
A detail About Dornier Group — The Dornier Group, grounded out of Germany is basically engaged in the business of a host of engineering services with a focus on the structure Development Member. Besides the headquarters located in Germany, Dornier has branch services in Eastern Europe, The Middle East, South Africa, and India. Dornier employs 2000 staff deputized across 18 locales in 13 Countries around the world with a normal of 1500 completed systems every time.
While conventionally working in close affinity with arising nations towards working the pining needs for introductory amenities like Renewable Energy, Power, Clean Water, Affordable Housing, etc. Dornier offers a complete portfolio of services for structure development in the fields of Mobility, Nuclear Services for Power & Renewable Energy, and water.
About Vikas Lifecare Limited Vikas Lifecare Ltd.( VLL) is an ISO 90012015 certified company, historically engaged in the business of manufacturing Polymer and Rubber composites and Specialty Complements for Plastics, Synthetic & Natural Rubbers. The company has been conventionally engaged in colorful business parts including Polymer & Rubber Commodity( bulk consumption) composites and Master- Batches.
Manufacturing Up-Cycled composites from artificial post-consumer waste and scrap accouterments like EVA, PVC, PP, PE, etc., directly contributing to the Environment Protection enterprise from the Government of India and fulfilling the commanded EPR scores for the empires using hundreds of thousands of tonnes of plastic products and packaging accouterments. VLL is also a Del- Credere agent of ONGC — The oil painting and Natural Gas Corporation Ltd. ” Petro Additions Limited is a public sector undertaking producing a wide variety of base polymers and commodity plastic raw accouterments.
VLL has a division engaged in Agro Products Business, The Company is excluded from NAFED — The “ National AgriculturalCo-Operative Federation of India ” and HOFED — The “ Uttar Pradesh HorticulturalCo-Operative Marketing Federation ”. As a long-term business strategy, the company has most lately diversified its business interests beyond raw accouterments ( B2B businesses) and forayed into the B2C member with a host of consumer products for FMCG, Agro, and structure parts; paving way for aggressive business growth with adding intricately planned and named product portfolios via accessions, common gambles, and tie-ups.
VLL intends to establish and acquire businesses in different parts thereby expanding its business stakes and footmark across the country and beyond. The securities of the Company are listed on both the Stock Exchanges, BSE (Scrip Code 542655) and NSE (Scrip Code VIKASLIFE).
0 notes
Text
Vikas Lifecare Ltd’s Qualified Institutions Placement of 10,75,26,881 equity shares of the face value of ₹ 1/-
Vikas Lifecare Ltd. wishes to enlighten everyone that the Board in regards to Heads of the Association, at its social event held today, November 24, 2022, has decided that:
1) In help to the association’s earlier clue dated November 15, 2022, for the opening shot of the QIP Issue (Qualified Establishments Course of action of 10,75,26,881 worth parts of the possible worth of ₹ 1/ — ):
a) upheld the finish of the Issue today (for instance November 24, 2022) post receipt of purpose structures and the resources in the escrow account from the certified institutional buyers according to the specifics of the Issue;
b) Concluded that, according to the SEBI ICDR Rules, the issue cost at ₹ 4.65 per Worth Proposition (counting a premium of ₹ 3.65 per Worth Deal), which is at a discount of ₹ 0.23 per Worth Proposal, for instance, ~4.71% to the floor cost of ₹ 4.88 per (decided in like manner according to the situation embraced under Rule 176 of the SEBI ICDR Rules and suggested in before correspondences), for the value proposals to be apportioned to the certified institutional buyers in the ongoing tranche;
c) upheld and settled the Confirmation of Allocation Note (“CAN”) to be transported off to qualified institutional buyers, hinting to them of the task of Significant worth Proposals according to the Issue; and
d) supported and took on the course of action report dated November 24, 2022; and
e) Dispersion of 10,75,26,881 Worth Proposals at the issue cost to the certified institutional buyers according to the states of the issue, a summary of allottees will be submitted through an alternate correspondence. Further, encased assuming no one minds, find joined the summary of allottees (who have been administered more than 5% of the Worth Offers introduced in the issue), put aside as Annexure 1.
2) Noticed the perfection of the divestment of the entire stake in Advik Labs Limited (CIN: L74899HR1994PLC038300) as for the agreed leave plan. The prominent disclosure of the communicated disinvestment of significant worth hypothesis has been made, as determined in material SEBI Rules to both the exchanges where the securities are recorded for instance BSE (Bombay Stock Exchange) and NSE (Public Stock Exchange).
We request every one to take this on record leniently, and the comparable is treated as consistency under the applicable rules of the Insurances and Exchange Driving group of India Rules, 2015, as different.
0 notes
Text
Vikas Lifecare Ltd’s Qualified Institutions Placement of 10,75,26,881 equity shares of the face value of ₹ 1/-
Vikas Lifecare Ltd. wishes to illuminate everybody that the Board regarding Heads of the Organization, at its gathering held today, November 24, 2022, has in addition to other things endorsed the accompanying:
1) In assistance to the organization’s prior hint dated November 15, 2022, for the kickoff of the QIP Issue (Qualified Foundations Arrangement of 10,75,26,881 value portions of the presumptive worth of ₹ 1/ — ):
a) supported the conclusion of the Issue today (for example November 24, 2022) post receipt of use structures and the assets in the escrow account from the qualified institutional purchasers as per the particulars of the Issue;
b) determined and approved, as per the SEBI ICDR Guidelines, the issue cost at ₹ 4.65 per Value Offer (counting a premium of ₹ 3.65 per Value Offer), which is at a rebate of ₹ 0.23 per Value Offer for example ~4.71% to the floor cost of ₹ 4.88 per (determined accordingly as per the equation endorsed under Guideline 176 of the SEBI ICDR Guidelines and implied in before correspondences), for the Value Offers to be dispensed to the qualified institutional purchasers in the current tranche;
c) supported and settled the Confirmation of Allocation Note (“CAN”) to be shipped off to qualified institutional purchasers, insinuating them of the assignment of Value Offers as per the Issue; and
d) endorsed and took on the arrangement report dated November 24, 2022; and
e) Distribution of 10,75,26,881 Value Offers at the issue cost to the qualified institutional purchasers as per the conditions of the issue, a rundown of allottees will be submitted through a different correspondence. Further, encased if it’s not too much trouble, track down joined the rundown of allottees (who have been dispensed over 5% of the Value Offers presented in the issue), set apart as Annexure 1.
2) Observed the culmination of the divestment of the whole stake in Advik Labs Restricted (CIN: L74899HR1994PLC038300) with respect to the concurred leave plan. The fundamental revelation of the expressed disinvestment of value speculation has been made, as specified in material SEBI Guidelines to both the trades where the protections are recorded for example BSE (Bombay Stock Trade) and NSE (Public Stock Trade).
We demand everybody to mercifully take this on record, and the equivalent is treated as consistency under the relevant guidelines of the Protections and Trade Leading body of India (Posting Commitments and Exposure Prerequisites) Guidelines, 2015, as changed.
0 notes